Back to overview

Gene Technology Act

}

Summary

The Norwegian Gene Technology Act came into force on 1 September 1993. It is an implementation of the EU directives EEC90/219 (Contained use) and EEC90/220 (Deliberate release) according to the economic agreement between Norway and EU (EEA). The directive on deliberate release has since been replaced by a new directive, EU/1829/2003. The main difference between the old directive and this new one from 2003 is that EU has placed a limit for content of GM traces in products and that if the product contains more than 2% of a genetically modified ingredient, the product must be labelled that it contains GMO.

Thumbnail image for The Norwegian Gene Technology Act came into force on 1 September 1993. It is an implementation of the EU directives EEC90/219 (Contained use) and EEC90/220 (Deliberate release) according to the economic agreement between Norway and EU (EEA). The directive on deliberate release has since been replaced by a new directive, EU/1829/2003. The main difference between the old directive and this new one from 2003 is that EU has placed a limit for content of GM traces in products and that if the product contains more than 2% of a genetically modified ingredient, the product must be labelled that it contains GMO.
Issuer

Norway

Year

1993

Region

Europe

Issuer (type)

The Norwegian Government (Regjeringen) (Government)

Policy Type

Disclosure

Geographical scope

National

Mandatory or voluntary

Mandatory


Main industries targeted
  • Agriculture, Forestry, Fishing & Hunting
  • Manufacturing
  • Accommodation & Food
  • Finance & Insurance
Restrictiveness

Very High

Sustainable Development Goals (SDGs)
  • SDG 3: Good Health and Well-being
  • SDG 5: Gender Equality
  • SDG 9: Industry, Innovation, and Infrastructure
  • SDG 11: Sustainable Cities and Communities

We have sent you the download link, please check your inbox.

Download again

Something went wrong when trying to download this file.

Try again